LIPOCINE INC

LPCN · NASDAQ

Updated at 2026-11-16 21:33:13

$1.66-2.92%
Today's High
$1.75
Today’s Low
$1.63
LIPOCINE INC (LPCN) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.63
Previous Close
$1.71
Volume
215.11K
Market Cap
$18.93M
P/E Ratio
--
EPS
$-1.86

Previous Day Range

$1.53$1.75

52-Week Range

$1.36$12.37

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
675 ARAPEEN DRIVE, SALT LAKE CITY, UT, UNITED STATES, 84108
Country
US
Listing Date
2014-03-21
Fiscal Year End
December
Shares Outstanding
8.24M
CIK
0001535955

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah.

Financial Metrics

Revenue

2026-09-30

$2.29M

2026-06-30

$190.09K

2026-03-31

$119.39K

2025-12-31

$1.14M

Operating Expenses

2026-09-30

$3.15M

2026-06-30

$3.03M

2026-03-31

$3.95M

2025-12-31

$3.64M

Net Income

2026-09-30

-$666.19K

2026-06-30

-$2.62M

2026-03-31

-$3.67M

2025-12-31

-$2.37M

Net Profit Margin

2026-09-30

-29.09%

2026-06-30

-1.37K%

2026-03-31

-3.07K%

2025-12-31

-206.92%

Earnings Per Share

2026-09-30

$-0.08

2026-06-30

$-0.32

2026-03-31

$-0.54

2025-12-31

$-0.42

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

-$666.19K

2026-06-30

-$2.6M

2026-03-31

-$3.65M

2025-12-31

-$2.35M

Effective Tax Rate

2026-09-30

--

2026-06-30

0%

2026-03-31

--

2025-12-31

0.01%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.